HRTX compared with ADMA: revenue, margins and what each company keeps, and the suppliers and customers both name

HRTXHeron Therapeutics, Inc.

Mkt capRevenueRevenue

ADMAAdma Biologics, Inc.

Mkt capRevenueRevenue

Compare

HRTXHeron Therapeutics, Inc.

ADMAAdma Biologics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

HRTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 10 '26±62.0%▼−31.74%×0.51

May 11 '26±32.7%▼−21.05%×0.65

Feb 26 '26±34.8%▲+11.11%×0.32

Nov 4 '25±24.3%▼−3.39%×0.14

ADMA

2 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26±15.2%▲+26.05%×1.72

Aug 6 '26±11.7%▲+8.64%×0.74

= impliedHRTX realized, solidADMA realized, hatchedOne scale, both sides: full bar = 63%× = |realized| ÷ impliedSource: market data

May 7 '26

±14.1%

▼−15.97%

×1.13

Feb 26 '26±10.9%▼−3.19%×0.29

HRTXHeron Therapeutics, Inc.

0.29▲+4.32%· post 0.29

Mkt cap$55.6MRevenue$38MQ2 FY26Revenue$155MFY25

ADMAAdma Biologics, Inc.

12.73▼−3.64%· post 12.74

ClosedNov 6 '26

Mkt cap$2.8BRevenue$141MQ3 FY26Revenue$510MFY25

Compare

ClosedNov 6 '26

HRTXHeron Therapeutics, Inc.

ADMAAdma Biologics, Inc.

0.29▲+4.32%post 0.29

Price

12.73▼−3.64%post 12.74

$55.6M

Mkt cap

$2.8B

Q2 FY26$38M

Revenue

$141MQ3 FY26

FY25$155M

Revenue

$510MFY25

HRTX0.29▲+4.32%vsADMA12.73▼−3.64%ClosedNov 6 '26